PainReform Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for PainReform Ltd. (PRFX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-14.59-9.34-8.79-7.25-4.05
Depreciation & Amortization0.020.020.020.010.00
Stock Based Compensation0.310.801.730.810.24
Change in Working Capital1.661.630.67-0.54-0.87
Change in Accounts Payable0.080.010.07-0.590.72
Change in Other Working Capital-0.011.580.600.41-1.59
Other Operating Activities-0.011.58-0.090.412.13
Net Cash from Operating Activities-12.62-6.68-6.46-6.55-2.56
Investing Activities
Capital Expenditures-0.01-0.01-0.01-0.05-0.01
Purchases of Investments0.00-1.00-6.000.000.00
Sales/Maturities of Investments0.007.000.000.000.00
Net Cash from Investing Activities-0.015.99-6.01-0.05-0.01
Financing Activities
Common Stock Issued5.351.700.006.0017.31
Other Financing Activities-1.24-0.930.00-0.450.00
Net Cash from Financing Activities8.864.620.007.4817.31
Summary
Effect of Forex Changes on Cash0.010.000.000.000.00
Net Change in Cash-3.773.93-12.470.8814.74
Cash at Beginning of Period8.044.1116.5715.690.00
Cash at End of Period4.278.044.1116.570.00
Free Cash Flow-12.63-6.69-6.47-6.60-2.57